Impairment of insulin signaling pathway PI3K/Akt/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective …

K Ramasubbu, V Devi Rajeswari - Molecular and Cellular Biochemistry, 2023 - Springer
Insulin resistance is common in type 2 diabetes mellitus (T2DM), neurodegenerative
diseases, cardiovascular diseases, kidney diseases, and polycystic ovary syndrome …

Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity

S Eržen, G Tonin, D Jurišić Eržen, J Klen - International Journal of …, 2024 - mdpi.com
Diabetes mellitus is a devastating chronic metabolic disease. Since the majority of type 2
diabetes mellitus patients are overweight or obese, a novel term—diabesity—has emerged …

Unraveling the molecular crossroads: T2DM and Parkinson's disease interactions.

T LIU, X KONG, J WEI - Biocell, 2024 - search.ebscohost.com
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by persistent
hyperglycemia. In recent times, an elevated risk of Parkinson's disease (PD) development …

Parkinson's Disease and Type 2 Diabetes Mellitus: Interrelated Pathogenetic Mechanisms and Common Therapeutic Approaches

AY Troshneva, AS Ametov - Neuroscience and Behavioral Physiology, 2023 - Springer
This review discusses the epidemiological, clinical, and pathophysiological aspects of the
relationship between Parkinson's disease (PD) and type 2 diabetes mellitus (DM2). DM2 …

БОЛЕЗНЬ ПАРКИНСОНА И САХАРНЫЙ ДИАБЕТ 2-ГО ТИПА: СВЯЗЬ МЕХАНИЗМОВ ПАТОГЕНЕЗА И ОБЩИЕ ТЕРАПЕВТИЧЕСКИЕ ПОДХОДЫ

АЮ ТРОШНЕВА, АС АМЕТОВ - ЖУРНАЛ НЕВРОЛОГИИ И …, 2022 - elibrary.ru
В обзорной статье рассматриваются эпидемиологические, клинические и
патофизиологические аспекты связи болезни Паркинсона (БП) и сахарного диабета 2 …